Effect of the Administration of Monofluorophosphate on Alpha-Macroglobulin Levels and the Clinical Course of Pancreatitis in Rats

Abstract

Clinical course of pancreatitis depends partially on the proteinases-antiproteinases balance. Monofluorophosphate (CAS 10163-15-2, MFP) binds to plasmatic antiproteinase alpha-macroglobulin (AM), modifies its homeostasis and, as a consequence, has potential effects on the progression of pancreatitis and other inflammatory processes. The progress of incomplete closed duodenal loop induced pancreatitis was studied in rats with AM homeostasis perturbed by the oral administration of MFP. Twelve rats received 80 µmol MFP/day orally for one month before the induction of pancreatitis. Controls did not receive MFP. Plasmatic amylase activity and AM levels were measured. The day of death was recorded and histopathology of pancreas was performed. Higher survival and less histopathologic changes were observed in rats treated with MFP previous to pancreatitis compared to rats without MFP. Amylase activities were higher in controls and AM levels decreased significantly in controls respect to MFP-treated animals.

Higher survival, lower amylasemia and less pancreatic damage in MFP-treated animals suggest a protective effect of the drug in the clinical course of pancreatitis.

Key words

CAS 10163-15-2 - Macroglobulin - Monofluorophosphate, anti-pancreatitic activity, effect on alpha-macroglobulin levels - Pancreatitis

• Literature

• 1 Saluja AK, Steer MLP. Patophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion. 1999; 60 (1) 27-33
• 2 Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med. 2001; 164: 162-170
• 3 Norton ID, Cain JE. Optimising outcomes in acute pancreatitis. Drugs. 2001; 61 (11) 1581-1591
• 4 Seta T, Noguchi Y, Shimada T, Shi Kata S, Fukui T. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol. 2004; 16 (12) 1287-1293
• 5 Cavalini G, Frulloni L. Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results. JOP, J Pancreas. 2003; 4 (1) 75-82
• 6 Borth W. α2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FABEB J. 1992; 6: 3345-3353
• 7 Sottrup-Jensen L. α-macroglobulins: structure, shape and mechanism of proteinase complex formation. J Biol Chem. 1989; 264: 11539-11542
• 8 Umans L, Seneels L, Overbergh L, Stas L, Van Leuven F. Alpha 2-macroglobulin and murino globulin-1 deficienct mice. A mouse model for acute pancreatitis. Am J Pathol. 1999; 155 (3) 983-993
• 9 Lasson A, Laurell AB, Ohlsson K. Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man. Scand J Gastroenterol. 1985; 20 (3) 335-345
• 10 Sebert JL, Richard P, Mennecier I, Bisset JP, Loeb G. Monofluorophosphate increase lumbar bone density in osteopenic patients: A double-masked ramdomized study. Osteoporosis Int. 1995; 5: 108-114
• 11 Delmas PD, Dupuis J, Duboeuf F, Chapuy MC. Meunier PI. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Mineral Res. 1990; 5: S143-S147
• 12 Rigalli A, Esteban L, Pera L, Puche RC. Binding of monofluorophosphate to α-2-macroglobulin and C3. Calcif Tissue Int. 1997; 60 (1) 86-89
• 13 Pera L, Rigalli A, Morosano M, Masoni A, Bocanera R, Tozzini R. Niveles plasmáticos de α2-macroglobulina (α2M) y C3 en el tratamiento crónico con MFP. Rev Argentina Endocrinol Metab. 1996; 33: 244-
• 14 Esteban L, Rigalli A, Puche RC. Metabolism of the complex monofluorophosphate-α-2-macroglobulin in the rat. Medicina (B Aires). 1999; 59: 151-156
• 15 Calderari S, Font MT, Garroq O, Martínez SM, Puche RC, Tarrés MC. The inbred IIM/Fm stock. Rat Newsletter. 1991; 25: 28-29
• 16 Guide for the care and use of laboratory animals. Publication N° 86-23, revised. National Institutes of Health; Bethesda, MD (USA): 1985
• 17 Sugimoto M, Takada T, Yasuda H. A new experimental pancreatitis by incomplete closed duodenal loop. Pancreas. 2004; 28: 112-119
• 18 Hoffmann EM, Muetzel S, Becker K. A modified dot-blot method of protein determination applied in the tannin-protein precipitation assay to facilitate the evaluation of tannin activity in animal feeds. Br J Nutr. 2002; 87: 421-426
• 19 Graph Pad Prism [computer program]. Version 2.0. San Diego, CA (USA): GraphPad Software; 1994
• 20 Hoogerwerf WA. Pharmacological management of pancreatitis. Curr Opin Pharmacol. 2005; 5: 578-582
• 21 Rigalli A, Ballina JC, Beinlich A, Alloatti R, Puche RC. Pharmacokinetics differences between sodium fluoride and sodium monofluorphosphate and comparative bone mass increasing activity of both compounds, in the rat. Arzneimittel-Forschung (Drug Research). 1994; 44: 762-766
• 22 Hegyi P, Rakonczay Z, Sári R, Lonovics J, Takács T, Czakó L. L-arginine-induced experimental pancreatitis. World J Gastroenterol. 2004; 10: 2003-2009
• 23 Weidenbach H, Lerch MM, Schoenberg MH, Gress TM, Turi S, Adler G. Characterization of a non-invasive, vascular model of acute necrotizing pancreatitis. J Gastroenterol. 1996; 34: 9-14